Quarterly Consolidated Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7341374

Concept 2023-06-01 to
2024-02-29
2022-06-01 to
2023-02-28
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
25,942,000,000 JPY
24,232,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.